Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure

Bibliographic Details
Main Authors: Kenan Yalta, Cafer Zorkun
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Indian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483217309008
id doaj-c8e6f3f4ba38411e8bc7675b04a0b881
record_format Article
spelling doaj-c8e6f3f4ba38411e8bc7675b04a0b8812020-11-24T20:55:20ZengElsevierIndian Heart Journal0019-48322018-01-0170119610.1016/j.ihj.2017.11.003Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failureKenan YaltaCafer Zorkunhttp://www.sciencedirect.com/science/article/pii/S0019483217309008Left ventricular reverse remodellingSystolic heart failureSoluble ST2Prognosis
collection DOAJ
language English
format Article
sources DOAJ
author Kenan Yalta
Cafer Zorkun
spellingShingle Kenan Yalta
Cafer Zorkun
Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
Indian Heart Journal
Left ventricular reverse remodelling
Systolic heart failure
Soluble ST2
Prognosis
author_facet Kenan Yalta
Cafer Zorkun
author_sort Kenan Yalta
title Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_short Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_full Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_fullStr Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_full_unstemmed Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
title_sort soluble st2 biomarker and reverse remodelling in patients with systolic heart failure
publisher Elsevier
series Indian Heart Journal
issn 0019-4832
publishDate 2018-01-01
topic Left ventricular reverse remodelling
Systolic heart failure
Soluble ST2
Prognosis
url http://www.sciencedirect.com/science/article/pii/S0019483217309008
work_keys_str_mv AT kenanyalta solublest2biomarkerandreverseremodellinginpatientswithsystolicheartfailure
AT caferzorkun solublest2biomarkerandreverseremodellinginpatientswithsystolicheartfailure
_version_ 1716791741655285760